Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rank regression in stability analysis.

Ying Qing Chen1, Annpey Pong, Biao Xing

  • 1Division of Biostatistics, School of Public Health, University of California, Berkeley, California 94720, USA. yqchen@stat.berkeley.edu

Journal of Biopharmaceutical Statistics
|August 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating attributable risk functions for censored time-to-event in disease prevention research.

Lifetime data analysis·2026
Same author

Research on Denoising Methods for Magnetocardiography Signals in a Non-Magnetic Shielding Environment.

Sensors (Basel, Switzerland)·2025
Same author

What drives adolescent girls and young women's decisions to persist on PrEP? Results of a comparative qualitative study from a DREAMS program in western Kenya.

AIDS care·2025
Same author

The Diagnosis and Treatment of Solitary Fibrous Tumor of the Parotid Gland.

Ear, nose, & throat journal·2025
Same author

Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial.

American heart journal·2025
Same author

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial.

Kidney diseases (Basel, Switzerland)·2025

This study introduces new rank-based regression methods for analyzing pharmaceutical stability data when standard assumptions are unmet. These rank-based approaches offer robust alternatives for determining drug shelf life and potency over time.

Area of Science:

  • Pharmaceutical Science
  • Biostatistics
  • Statistical Modeling

Background:

  • Stability data are crucial for determining pharmaceutical product shelf life, particularly drug potency over time.
  • Traditional statistical methods like linear regression models are commonly used but often rely on strict parametric assumptions.
  • These assumptions, such as normality of data or error structures, can limit the applicability of standard models in real-world pharmaceutical stability studies.

Purpose of the Study:

  • To propose and evaluate novel rank-based regression procedures for analyzing pharmaceutical stability data.
  • To address limitations of traditional parametric models when dealing with unspecified error structures in semiparametric regression.
  • To provide robust statistical tools for accurate shelf-life determination and potency assessment.

Related Experiment Videos

Main Methods:

  • Development of rank-based regression techniques tailored for semiparametric stability data analysis.
  • Utilizing Monte Carlo simulations to assess the performance and reliability of the proposed methods.
  • Application of the procedures to a practical pharmaceutical stability dataset.

Main Results:

  • The proposed rank-based regression procedures demonstrate effectiveness in analyzing stability data with unspecified error distributions.
  • Numerical studies confirm the robustness and validity of the new methods compared to traditional approaches.
  • The practical example illustrates the successful application of these techniques in a real-world scenario.

Conclusions:

  • Rank-based regression offers a valuable and robust alternative for pharmaceutical stability data analysis, especially when parametric assumptions are violated.
  • The developed methods provide reliable tools for estimating drug shelf life and monitoring potency.
  • Further research and application of these procedures can enhance the accuracy and reliability of pharmaceutical stability assessments.